Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Spanish Lung Cancer Group"
Count: 26
Selected: 0
| NCT ID | Title |
|---|
| NCT03526887 | Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC | ||
| NCT03496766 | Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS | ||
| NCT03156868 | Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma | ||
| NCT03526900 | Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis | ||
| NCT03081689 | Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients | ||
| NCT02941458 | Thoracic Tumours Register | ||
| NCT04344002 | LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) | ||
| NCT00913705 | Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer | ||
| NCT00883480 | Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma | ||
| NCT00446225 | Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR | ||
| NCT03293680 | Pembrolizumab in Elderly Patients With Advanced Lung Cancer | ||
| NCT03094286 | Durvalumab in Solid Tumors | ||
| NCT03363139 | T790M Mutation Testing in Blood by Different Methodologies | ||
| NCT02709720 | Locally Advanced Trial of Tri-weekly Metronomic Oral Vinorelbine and Cisplatin as Induction Therapy and Subsequent Concomitance With Radiation Therapy in Patients With Unresectable Non Small Cell Lung Cancer (NSCLC) | ||
| NCT03132493 | Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient | ||
| NCT01513174 | Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone | ||
| NCT01088906 | Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC | ||
| NCT00617656 | Multicenter, Predictive, Prospective, Phase III, Open, Randomized, Pharmacogenomic Study in Patients With Advanced Lung Carcinoma | ||
| NCT00478699 | Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) | ||
| NCT01814163 | Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab | ||
| NCT00503971 | Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. | ||
| NCT01652820 | Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer | ||
| NCT01562028 | BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) | ||
| NCT02183870 | EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG |
